These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17021367)

  • 1. Fatty acid metabolism, the central nervous system, and feeding.
    Ronnett GV; Kleman AM; Kim EK; Landree LE; Tu Y
    Obesity (Silver Spring); 2006 Aug; 14 Suppl 5():201S-207S. PubMed ID: 17021367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid metabolism as a target for obesity treatment.
    Ronnett GV; Kim EK; Landree LE; Tu Y
    Physiol Behav; 2005 May; 85(1):25-35. PubMed ID: 15878185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic C75 treatment of diet-induced obese mice increases fat oxidation and reduces food intake to reduce adipose mass.
    Thupari JN; Kim EK; Moran TH; Ronnett GV; Kuhajda FP
    Am J Physiol Endocrinol Metab; 2004 Jul; 287(1):E97-E104. PubMed ID: 14736702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The connections between C75 and obesity drug-target pathways.
    Kuhajda FP; Landree LE; Ronnett GV
    Trends Pharmacol Sci; 2005 Nov; 26(11):541-4. PubMed ID: 16169094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of food intake and energy expenditure by hypothalamic malonyl-CoA.
    Lane MD; Wolfgang M; Cha SH; Dai Y
    Int J Obes (Lond); 2008 Sep; 32 Suppl 4():S49-54. PubMed ID: 18719599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C75 alters central and peripheral gene expression to reduce food intake and increase energy expenditure.
    Tu Y; Thupari JN; Kim EK; Pinn ML; Moran TH; Ronnett GV; Kuhajda FP
    Endocrinology; 2005 Jan; 146(1):486-93. PubMed ID: 15498887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid synthase-dependent neoplastic lipogenesis as the mechanism of gamma-linolenic acid-induced toxicity to tumor cells: an extension to Nwankwo's hypothesis.
    Menendez JA; Colomer R; Lupu R
    Med Hypotheses; 2005; 64(2):337-41. PubMed ID: 15607568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatty acid metabolism in breast cancer cells: differential inhibitory effects of epigallocatechin gallate (EGCG) and C75.
    Puig T; Vázquez-Martín A; Relat J; Pétriz J; Menéndez JA; Porta R; Casals G; Marrero PF; Haro D; Brunet J; Colomer R
    Breast Cancer Res Treat; 2008 Jun; 109(3):471-9. PubMed ID: 17902053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C75 increases peripheral energy utilization and fatty acid oxidation in diet-induced obesity.
    Thupari JN; Landree LE; Ronnett GV; Kuhajda FP
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9498-502. PubMed ID: 12060712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid synthase inhibition activates AMP-activated protein kinase in SKOV3 human ovarian cancer cells.
    Zhou W; Han WF; Landree LE; Thupari JN; Pinn ML; Bililign T; Kim EK; Vadlamudi A; Medghalchi SM; El Meskini R; Ronnett GV; Townsend CA; Kuhajda FP
    Cancer Res; 2007 Apr; 67(7):2964-71. PubMed ID: 17409402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatty acid synthase inhibition triggers apoptosis during S phase in human cancer cells.
    Zhou W; Simpson PJ; McFadden JM; Townsend CA; Medghalchi SM; Vadlamudi A; Pinn ML; Ronnett GV; Kuhajda FP
    Cancer Res; 2003 Nov; 63(21):7330-7. PubMed ID: 14612531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of carnitine palmitoyltransferase-1 for the treatment of obesity.
    Kuhajda FP; Ronnett GV
    Curr Opin Investig Drugs; 2007 Apr; 8(4):312-7. PubMed ID: 17458181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological stimulation of brain carnitine palmitoyl-transferase-1 decreases food intake and body weight.
    Aja S; Landree LE; Kleman AM; Medghalchi SM; Vadlamudi A; McFadden JM; Aplasca A; Hyun J; Plummer E; Daniels K; Kemm M; Townsend CA; Thupari JN; Kuhajda FP; Moran TH; Ronnett GV
    Am J Physiol Regul Integr Comp Physiol; 2008 Feb; 294(2):R352-61. PubMed ID: 18056987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of malonyl-CoA in the hypothalamic control of food intake and energy expenditure.
    Lane MD; Hu Z; Cha SH; Dai Y; Wolfgang M; Sidhaye A
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1063-7. PubMed ID: 16246046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of fatty acid synthase for lung cancer treatment.
    Orita H; Coulter J; Lemmon C; Tully E; Vadlamudi A; Medghalchi SM; Kuhajda FP; Gabrielson E
    Clin Cancer Res; 2007 Dec; 13(23):7139-45. PubMed ID: 18056164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased fatty acid synthase is a therapeutic target in mesothelioma.
    Gabrielson EW; Pinn ML; Testa JR; Kuhajda FP
    Clin Cancer Res; 2001 Jan; 7(1):153-7. PubMed ID: 11205903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipids in the control of food intake.
    Fantino M
    Curr Opin Clin Nutr Metab Care; 2011 Mar; 14(2):138-44. PubMed ID: 21252653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Weight reduction by Chinese medicinal herbs may be related to inhibition of fatty acid synthase.
    Tian WX; Li LC; Wu XD; Chen CC
    Life Sci; 2004 Mar; 74(19):2389-99. PubMed ID: 14998716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of food intake by inhibitors of fatty acid synthase.
    Bouchard C
    N Engl J Med; 2000 Dec; 343(25):1888-9. PubMed ID: 11117983
    [No Abstract]   [Full Text] [Related]  

  • 20. C75 is converted to C75-CoA in the hypothalamus, where it inhibits carnitine palmitoyltransferase 1 and decreases food intake and body weight.
    Mera P; Bentebibel A; López-Viñas E; Cordente AG; Gurunathan C; Sebastián D; Vázquez I; Herrero L; Ariza X; Gómez-Puertas P; Asins G; Serra D; García J; Hegardt FG
    Biochem Pharmacol; 2009 Mar; 77(6):1084-95. PubMed ID: 19094968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.